Sanjeev Saksena is a Cardiology physician affiliated with Rutgers. OpenAlex indexes 419 publications with 13,397 citations (h-index 48); ClinicalTrials.gov lists 3 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Clinical Cardiac Electrophysiology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
161 Washington Valley Rd
Suite 201
Warren, NJ 070597176
Telephone
732-302-9988Registry record last updated 15 Jan 2010.
Clinical trials
- Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure
Sponsor: Electrophysiology Research Foundation
- EdoxabaN or Warfarin Therapy In Device Procedures in Patients With Non-Valvular Atrial Fibrillation
Sponsor: Electrophysiology Research Foundation
- Intra-Cardiac Echocardiography Guided Cardioversion(ICE-CHIP) Study
Sponsor: EP MedSystems
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20242 payments
- SANOFI-AVENTIS U.S. LLCProgram year20233 payments$13,928openpaymentsdata.cms.gov ↗
- Medtronic, Inc.Program year20232 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
85.4%Beta blocker19.1%Metoprolol Succinate57%Carvedilol31%Sotalol12%Part D<11 patientsStatin16.7%Atorvastatin Calcium100%Part D≥23 patients+ 8 more classes in this area
Blood & clotting
8.3%P2Y12 inhibitor5.7%Clopidogrel100%Part D<11 patientsFactor Xa inhibitor2.5%Eliquis100%Part D<11 patientsMetabolism & gastrointestinal
6.4%Potassium supplement3.8%Potassium Chloride100%Part D<11 patientsSGLT2 inhibitor2.5%Farxiga100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Reynold Panettieri, MD
Rutgers
Jacob Sage, MD
Rutgers
Brenda Kurnik, MD
Rutgers
Dale Schaar
Rutgers
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”